control stable expression lentivirus (luc-shctrl) (Shanghai GenePharma)
Structured Review
Control Stable Expression Lentivirus (Luc Shctrl), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+shctrl/control+stable+expression+lentivirus++luc+shctrl+/pm31681988-68-27-38
Average 90 stars, based on 1 article reviews
Images
Related Articles
Plasmid Preparation:Article Title: GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. Article Snippet: Funding information Fund for Scientific Research of The First Hospital of China Medical University, Grant/ Award Number: fsfh1514; Natural Science Foundation of Liaoning Province, Grant/ Award Number: 2015020561; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.18293 Abstract Non‐small‐cell lung cancer (NSCLC) is a cancer with high morbidity and mortality.. We aimed to define the effect of Go‐Ichi‐Ni‐San complex subuint 2 (GINS2) acting on NSCLC.. The expressions of GINS2 in NSCLC tissues and cells were detected using real‐ time quantitative polymerase chain reaction, western blot, and immunohistochemistry (IHC). Control:Article Title: GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. Article Snippet: Funding information Fund for Scientific Research of The First Hospital of China Medical University, Grant/ Award Number: fsfh1514; Natural Science Foundation of Liaoning Province, Grant/ Award Number: 2015020561; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.18293 Abstract Non‐small‐cell lung cancer (NSCLC) is a cancer with high morbidity and mortality.. We aimed to define the effect of Go‐Ichi‐Ni‐San complex subuint 2 (GINS2) acting on NSCLC.. The expressions of GINS2 in NSCLC tissues and cells were detected using real‐ time quantitative polymerase chain reaction, western blot, and immunohistochemistry (IHC). Over Expression:Article Title: GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. Article Snippet: Funding information Fund for Scientific Research of The First Hospital of China Medical University, Grant/ Award Number: fsfh1514; Natural Science Foundation of Liaoning Province, Grant/ Award Number: 2015020561; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.18293 Abstract Non‐small‐cell lung cancer (NSCLC) is a cancer with high morbidity and mortality.. We aimed to define the effect of Go‐Ichi‐Ni‐San complex subuint 2 (GINS2) acting on NSCLC.. The expressions of GINS2 in NSCLC tissues and cells were detected using real‐ time quantitative polymerase chain reaction, western blot, and immunohistochemistry (IHC). Luciferase:Article Title: GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. Article Snippet: Funding information Fund for Scientific Research of The First Hospital of China Medical University, Grant/ Award Number: fsfh1514; Natural Science Foundation of Liaoning Province, Grant/ Award Number: 2015020561; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.18293 Abstract Non‐small‐cell lung cancer (NSCLC) is a cancer with high morbidity and mortality.. We aimed to define the effect of Go‐Ichi‐Ni‐San complex subuint 2 (GINS2) acting on NSCLC.. The expressions of GINS2 in NSCLC tissues and cells were detected using real‐ time quantitative polymerase chain reaction, western blot, and immunohistochemistry (IHC). Expressing:Article Title: GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. Article Snippet: Funding information Fund for Scientific Research of The First Hospital of China Medical University, Grant/ Award Number: fsfh1514; Natural Science Foundation of Liaoning Province, Grant/ Award Number: 2015020561; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.18293 Abstract Non‐small‐cell lung cancer (NSCLC) is a cancer with high morbidity and mortality.. We aimed to define the effect of Go‐Ichi‐Ni‐San complex subuint 2 (GINS2) acting on NSCLC.. The expressions of GINS2 in NSCLC tissues and cells were detected using real‐ time quantitative polymerase chain reaction, western blot, and immunohistochemistry (IHC). Synthesized:Article Title: GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. Article Snippet: Funding information Fund for Scientific Research of The First Hospital of China Medical University, Grant/ Award Number: fsfh1514; Natural Science Foundation of Liaoning Province, Grant/ Award Number: 2015020561; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.18293 Abstract Non‐small‐cell lung cancer (NSCLC) is a cancer with high morbidity and mortality.. We aimed to define the effect of Go‐Ichi‐Ni‐San complex subuint 2 (GINS2) acting on NSCLC.. The expressions of GINS2 in NSCLC tissues and cells were detected using real‐ time quantitative polymerase chain reaction, western blot, and immunohistochemistry (IHC). |

